Cargando…
Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAs
Background: Colon cancer (CC) is a prevalent malignant tumor that affects people all around the world. In this study, N6-methylandenosine-related long non-coding RNAs (m6A-related lncRNAs) in 473 colon cancers and 41 adjacent tissues of CC patients from The Cancer Genome Atlas (TCGA) were investigat...
Autores principales: | Wang, Yongfeng, Zhang, Dongzhi, Li, Yuxi, Wu, Yue, Ma, Haizhong, Jiang, Xianglai, Fu, Liangyin, Zhang, Guangming, Wang, Haolan, Liu, Xingguang, Cai, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313068/ https://www.ncbi.nlm.nih.gov/pubmed/37396046 http://dx.doi.org/10.3389/fgene.2023.906346 |
Ejemplares similares
-
Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs
por: Zhang, Li, et al.
Publicado: (2021) -
N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer
por: Zhang, Hongliang, et al.
Publicado: (2021) -
Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma
por: Zhang, Pei, et al.
Publicado: (2021) -
Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine–Related lncRNAs Profiling
por: Yin, Lu, et al.
Publicado: (2022) -
N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
por: Zhang, Yuying, et al.
Publicado: (2021)